Loading...

127 posters, 2 topics, 24 sessions, 326 authors, 85 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

2023 ACP ANNUAL SESSION

October 25-28 | San Diego, CA

2023 ACP ANNUAL SESSION banner

132

Prosthodontic Treatment Considerations for Patients with Obstructive Sleep Apnea

Part of Topic

Original Research

Prosthodontic Treatment Considerations for Patients with Obstructive Sleep Apnea 

Moran, Tess, DDS; Shah, Kumar, BDS, MS, FACP, FAP

University of California, Los Angeles School of Dentistry

Introduction

Obstructive sleep apnea (OSA) is a sleep-related breathing disorder characterized by loud snoring and apneas/hypopneas despite respiratory movements. Untreated OSA may lead to cardiovascular (CV) and metabolic comorbidities1. 

oAssociated with HTN, DMII, PE/DVT, asthma, obesity, RLS, hypothyroidism
oWorldwide prevalence estimated between 936 million-1 billion people (some countries’ >50% prevalence)
oGERD/LPR: comorbid in 40-60% OSA patients/associated with erosive wear2

OSA has implications on prosthodontic treatment: untreated OSA is often associated with caries, temporomandibular joint pathology, loss of restorative space from heavy wear, and breakdown of natural and restored dentition, while successful treatment of OSA may cause significant changes in occlusion. Therefore, considerations for treatment of these patients must be made pre-prosthetically, during treatment, and in the maintenance phase.

Case Report

A 58-year-old male of the Tule River Tribe presents with chief complaint of “I want to keep my teeth.”

 

Medical history positive

for severe OSA, GERD.

 

Findings include severe wear (correlates with OSA and GERD5), large mandibular tori, loss of tongue mobility, and diurnal apneic episodes.

 

Mandibular tori removal indicated.

After removal of one torus, patient reports improved breathing, tongue mobility, daytime sleepiness, & continuous positive airway pressure (CPAP/PAP) tolerance

Figure 1: Intraoral view, MIP

Figure 2: Occlusal view, maxilla

Figure 3a: Initial occlusal view, mandible; Note lingual frenum

Figure 3b: Mid-treatment occlusal view, mandible

Screening1 oEvaluate for related dental symptoms oSevere wear of the teeth, physical airway obstruction (large tori, high Mallampati class, large tonsils), comorbid conditions (RLS, asthma, GERD, HTN, DMII) oEpworth Sleepiness Scale, 0-3: >10 indicates excessive sleepiness oSTOP-BANG: 0-2 Low risk; 3-4 Intermediate risk; 5-8 High risk o o o o o o o o o o o o Referrals oSleep medicine: Positive result on Epworth, STOP-BANG oGastroenterologist: Erosion, reported reflux, hoarse voice, throat clearing, excess mucus or postnasal drip o Diagnosis1 oGold standard: Polysomnography (PSG) in-lab (at-home possible) oObstructive sleep apnea (most common) vs. Central sleep apnea oSeverity based on Apnea-Hypopnea Index (AHI) : Mild (5-10), Moderate (15-30), Severe (>30) o Treatment1,4 oNon-invasive: Positional therapy oMild-mod: Oral Appliance Therapy (OAT - mandibular advancement) oSevere/symptomatic: Positive Airway Pressure (PAP) oSevere, intolerant to PAP, or adjunctive: Hypoglossal nerve stimulation, upper airway surgery, tracheostomy, bariatric surgery oProblem Evidence-Based Recommendation Altered occlusion due to CPAP secondary to pressure on teeth/PDL or OAT secondary to lateral pterygoid shortening and masseter/temporalis/medial pterygoid lengthening1,4 oPAP: Daytime intraoral orthotic; Titration of CPAP with occlusal splint (only protects splinted arch) oOAT: Conservative titration of mandibular advancement; Daytime intraoral orthotic; Isometric and passive jaw stretching (lat. pterygoid, masseter, temporalis) o Caries and erosion secondary to increased intraoral acid challenge and/or dry mouth due to OAT/PAP/ medications o oFluoride gel in intraoral orthotics; If patient does not need OAT or occlusal splint, patient can wear orthotics at night o Bruxing (awake/sleep)3,5 oOSA: Complete/partial airway collapse & associated decrease in oxygen leads to mandibular displacement and upper airway patency oMedication: Phenethylamines,  anticonvulsants, and SSRIs may contribute to bruxing oOSA: Occlusal splints associated with aggravation of OSA by airway obstruction; Recommend CPAP titration with occlusal splint in place oMedication: Ask prescribing physician if a change in medication is possible; Prescribe occlusal splint if patient does not have OSA OVD evaluation and/or restoration maintenance5 oRecommend daytime occlusal splint use oRecommend CPAP titration with occlusal splint in place

Problem Solving in the Treated Patient

1Epstein et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009

2Mahfouz et al. The Relationship Between Obstructive Sleep Apnea (OSA) and Gastroesophageal Reflux Disease (GERD) in Inpatient Settings: A Nationwide Study. Cureus. 2022.

3Wetselaar et al. Associations between tooth wear and dental sleep disorders: A narrative overview. J Oral Rehabil. 2019

4Sheats, Rose & Schell. (2017). Management of Side Effects of Oral Appliance Therapy for Sleep-Disordered Breathing. Journal of Dental Sleep Medicine. 5Nikolopoulou et al. Effects of occlusal stabilization splints on obstructive sleep apnea: a randomized controlled trial. J Orofac Pain. 2013.

2023 ACP ANNUAL SESSION » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.